Mina Chen

Mina Chen


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Developmental Cell
Verified
Journal Article
Closed access
JZJia Zou
Jia Zou
LZLiang Zhou
Liang Zhou
XDXiao-Xia Du
Xiao-Xia Du
YJYifei Ji
Yifei Ji
JXJia Xu
Jia Xu
BXBo Xiao
Bo Xiao

19 November 2014 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
YZYi Zou
Yi Zou
WJWanxiang Jiang
Wanxiang Jiang
JWJianqing Wang
Jianqing Wang
ZLZhongping Li
Zhongping Li
JZJunyan Zhang
Junyan Zhang
BXBo Xiao
Bo Xiao
Rheb1is an immediate early gene that functions to activate mammalian target of rapamycin (mTor) selectively in complex 1 (mTORC1). We have demonstrated previously that Rheb1 is essential for myelination in the CNS using aNestin-Credriver line that deletesRheb1in all neural cell lineages, and recent studies using oligodendrocyte-specificCNP-Crehave suggested a preferential role for mTORC1 is myelination in the spinal cord. Here, we examine the role of Rheb1/mTORC1 in mouse oligodendrocyte lineage using separate Cre drivers for oligodendrocyte progenitor cells (OPCs) includingOlig1-CreandOlig2-Creas well as differentiated and mature oligodendrocytes includingCNP-Cre and Tmem10-Cre. Deletion ofRheb1in OPCs impairs their differentiation to mature oligodendrocytes. This is accompanied by reduced OPC cell-cycle exit suggesting a requirement for Rheb1 in OPC differentiation. The effect of Rheb1 on OPC differentiation is mediated by mTor sinceOlig1-Credeletion ofmTorphenocopiesOlig1-Cre Rheb1deletion. Deletion ofRheb1in mature oligodendrocytes, in contrast, does not disrupt developmental myelination or myelin maintenance. Loss ofRheb1in OPCs or neural progenitors does not affect astrocyte formation in gray and white matter, as indicated by the pan-astrocyte marker Aldh1L1. We conclude that OPC-intrinsic mTORC1 activity mediated by Rheb1 is critical for differentiation of OPCs to mature oligodendrocytes, but that mature oligodendrocytes do not require Rheb1 to make myelin or maintain it in the adult brain. These studies reveal mechanisms that may be relevant for both developmental myelination and impaired remyelination in myelin disease.

1 August 2014 in Developmental Cell
Verified
Journal Article
Closed access
CHChao Huang
Chao Huang
MCMina Chen
Mina Chen
DPDejiang Pang
Dejiang Pang
DBDandan Bi
Dandan Bi
YZYi Zou
Yi Zou
BXBo Xiao
Bo Xiao

14 May 2010 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
KMKejie Mou
Kejie Mou
MCMina Chen
Mina Chen
QMQing Mao
Qing Mao
PWPeng Wang
Peng Wang
RNRenyong Ni
Renyong Ni
YLYanhui Liu
Yanhui Liu

30 September 2019 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
HTHonglin Tan
Honglin Tan
MCMina Chen
Mina Chen
DPDejiang Pang
Dejiang Pang
XXXiaoqiang Xia
Xiaoqiang Xia
CDChongyangzi Du
Chongyangzi Du
BXBo Xiao
Bo Xiao
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive loss of motor neurons. Improving neuronal survival in ALS remains a significant challenge. Previously, we identified Lanthionine synthetase C-like protein 1 (LanCL1) as a neuronal antioxidant defense gene, the genetic deletion of which causes apoptotic neurodegeneration in the brain. Here, we report in vivo data using the transgenic SOD1G93A mouse model of ALS indicating that CNS-specific expression of LanCL1 transgene extends lifespan, delays disease onset, decelerates symptomatic progression, and improves motor performance of SOD1G93A mice. Conversely, CNS-specific deletion of LanCL1 leads to neurodegenerative phenotypes, including motor neuron loss, neuroinflammation, and oxidative damage. Analysis reveals that LanCL1 is a positive regulator of AKT activity, and LanCL1 overexpression restores the impaired AKT activity in ALS model mice. These findings indicate that LanCL1 regulates neuronal survival through an alternative mechanism, and suggest a new therapeutic target in ALS.

1 January 2011 in Genetics and Molecular Research
Verified
Journal Article
Closed access
PWP. Wang
P. Wang
RNR.Y. Ni
R.Y. Ni
MCMina Chen
Mina Chen
KMK.J. Mou
K.J. Mou
QMQ. Mao
Q. Mao
YLY.H. Liu
Y.H. Liu
Peritumoral brain edema is a common complication of meningiomas. It is believed that vascular endothelial growth factor (VEGF), as an angiogenic factor, plays a vital role in edema formation. Aquaporin-4 (AQP4) is a small integral membrane protein that regulates water in the normal brain. However, the expression of AQP4 and its relationship to VEGF in edematous meningiomas are not well known. We studied tumor specimens of 59 human supratentorial meningiomas. Western blot analysis was used to detect the expression of AQP4, and double-labeling immunofluorescence histochemical staining was performed to determine the relationship between AQP4 and VEGF. The AQP4 expression was significantly higher in the edema group, in which the protein level was correlated with the extent of edema. Greater VEGF expression was also observed in the edema group, and a relationship between AQP4 and VEGF was found. We conclude that AQP4 is involved in peritumoral brain edema formation in meningiomas and is also closely related to the expression of VEGF.